66 results
DEFA14A
VIR
Vir Biotechnology Inc
14 May 24
Additional proxy soliciting materials
4:05pm
of the evolving global healthcare environment, and an unwavering commitment to driving innovation Unique and invaluable industry expertise, having both led … Officer (since 2024) Experienced leader in international healthcare with a focus on accelerating innovative therapeutics designed to ensure better patient
S-3ASR
EX-1.2
VIR
Vir Biotechnology Inc
3 Nov 23
Automatic shelf registration
4:33pm
.
(oo) Healthcare Laws. Except as described in the Registration Statement and the Prospectus, the Company: (i) has operated and currently operates its
8-K
EX-99.1
032y38aa783ybg435pz
3 Nov 22
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:06pm
8-K
EX-99.1
whzww6eknhe4d
9 Aug 22
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
4qeyrd2on4xbxq
5 May 22
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
px6b4x3mn
25 Mar 22
Other Events
4:10pm